Related references
Note: Only part of the references are listed.Combined Therapy of Dietary Fish Oil and Stearoyl-CoA Desaturase 1 Inhibition Prevents the Metabolic Syndrome and Atherosclerosis
J. Mark Brown et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides
M. E. El-Mesery et al.
CELL DIVISION (2009)
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment
Christine Carter-Kent et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Diet and nonalcoholic fatty liver disease
Ronald P. Mensink et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Fatty liver and chronic inflammation in Chinese adults
Pei-Wen Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients
David Garcia-Galiano et al.
OBESITY SURGERY (2007)
Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients
Mohammed M. H. Al-Gayyar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Giovanni Targher et al.
ATHEROSCLEROSIS (2007)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study
M Capanni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease
J Poniachik et al.
CYTOKINE (2006)
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
XL Jin et al.
HEPATOLOGY (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
Omega-3 polyunsaturated fatty acids: A pilot trial in non-alcoholic fatty liver disease
L. Spadaro et al.
JOURNAL OF HEPATOLOGY (2006)
Central fat excess in polycystic ovary syndrome:: Relation to low-grade inflammation and insulin resistance
JJ Puder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S
ES Ford
DIABETES CARE (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4
AR Weatherill et al.
JOURNAL OF IMMUNOLOGY (2005)
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
P Portincasa et al.
CLINICAL BIOCHEMISTRY (2005)
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy
P Colicchio et al.
ANNALS OF NUTRITION AND METABOLISM (2005)
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti et al.
GASTROENTEROLOGY (2002)